<DOC>
	<DOC>NCT01725776</DOC>
	<brief_summary>The purpose of this study is to investigate the concentration-effect relationship of inhaled milrinone after prophylactic administration in cardiac surgical patients with preoperative pulmonary hypertension undergoing cardiopulmonary bypass.</brief_summary>
	<brief_title>Inhaled Milrinone in Cardiac Surgery</brief_title>
	<detailed_description>Milrinone elimination will be verify with blood and urine samples analysis.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Patients scheduled for elective cardiac surgery under CPB High risk patients: NYHA class IIIII Preoperative diagnostic of pulmonary hypertension: Systolic pulmonary artery pressure (sPAP) &gt; 35 mm Hg; or Mean pulmonary artery pressure (mPAP) &gt; 25 mm Hg; or mAP/mPAP &lt; 3.0 (after induction of anesthesia). Open Heart Surgery Contraindication to transesophageal echocardiography (TEE) Hemodynamic instability before surgery Emergency surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Cardiopulmonary Bypass (CPB)</keyword>
</DOC>